Thyroid Cancer
Key guidelines for oncology healthcare professionals are listed below
| NICE Guideline | Thyroid cancer: assessment and management NG230 |
| NICE Technology Appraisal Guidance | Cabozantinib for treating medullary thyroid cancer TA516 |
| NICE Technology Appraisal Guidance | Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine TA535 |
| NICE Technology Appraisal Guidance | Selpercatinib for treating advanced thyroid cancer with RET alterations TA742 |
| NICE Technology Appraisal Guidance | Vandetanib for treating medullary thyroid cancer TA550 |
Guidelines
Access key guidelines for oncology healthcare professionals
Resources
All the major resources from the world of oncology
Podcasts
We bring you informative podcasts with UK oncology experts
Events
Don't miss the latest oncology events in the UK
